REPL Replimune Group Forecast, Technical & Fundamental Analysis

a developer of oncolytic immunotherapies

Industry Biotechnology

Get AI intraday signals

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for $1 only)

View a ticker or compare two or three

Compare

REPL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For REPL
(Try 14 days for $1 only)

Ad is loading...

A.I. Advisor

published Earnings

REPL is expected to report earnings to rise 4.48% to -85 cents per share on August 01

Replimune Group REPL Stock Earnings Reports

Q2'24

Est.

$-0.86

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.12

Q3'23

Missed

by $0.09

Q2'23

Beat

by $0.05

The last earnings report on May 16 showed earnings per share of -81 cents, missing the estimate of -76 cents. With 343.38K shares outstanding, the current market capitalization sits at 716.69M.

A.I. Advisor

published General Information

General Information

a developer of oncolytic immunotherapies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

500 Unicorn Park Drive

Phone

+1 781 222-9600

Employees

284

Web

https://www.replimune.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
FPPJX	11.69	-0.05	-0.43%
MFS Prudent Investor I
CIVVX	20.59	-0.11	-0.53%
Causeway International Value Inv
AEDMX	11.18	-0.06	-0.53%
American Century Emerging Markets R6
TROCX	26.41	-0.16	-0.60%
Touchstone Non-US ESG Equity I
CILRX	26.67	-0.41	-1.51%
Columbia Acorn International Sel Adv

REPL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, REPL has been loosely correlated with MDGL. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if REPL jumps, then MDGL could also see price increases.

Ticker / NAME	Correlation To REPL	1D Price Change %
REPL	100%	+2.34%
MDGL - REPL	56% Loosely correlated	+0.47%
AXON - REPL	41% Loosely correlated	-0.73%
ORMP - REPL	39% Loosely correlated	-1.36%
SWTX - REPL	35% Loosely correlated	+0.46%
AMRN - REPL	34% Loosely correlated	+0.87%
More